Status:

UNKNOWN

Effects of Peripheral Electrical Stimulation With Focused Ultrasound on Motor Symptoms in Parkinson's Patients

Lead Sponsor:

University Health Network, Toronto

Conditions:

Parkinson Disease

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Transcranial Ultrasound Stimulation (TUS) is an emerging non-invasive brain stimulation(NIBS) technique that can be used on both superficial and deep brain targets with a high spatial resolution as sm...

Detailed Description

There are 3 study visits and for all of them patients will remain in ON dopaminergic medication condition. Each visit will be a minimum of 7 days apart. Each visit will contain 1 of 3 combinations: ...

Eligibility Criteria

Inclusion

  • 18-90 years of age
  • Confirmed diagnosis of Parkinson's disease
  • Stable dopaminergic medication dose for a minimum of 4 weeks (applicable for PD patients only)

Exclusion

  • History of stroke or seizure
  • Comorbid dementia
  • Scored below 22 on the Montreal Cognitive Assessment (MoCA)
  • Has intracranial implant(s) or device(s)
  • Has an implanted cardiac pacemaker or implantable cardioverter-defibrillator (ICD)
  • Has a previous surgical intervention to treat the movement disorder such as lesioning or a Deep Brain Stimulation system in place.
  • Presence of metal implanted in body that is contraindicated in TMS/MRI/peripheral electrical stimulation
  • Pregnancy
  • Major depression/psychiatric disorder that in the opinion of the Investigator will affect patient's understanding of study procedures and willingness to abide by all procedures during the course of the study
  • Is on antipsychotics, anti-depressants, marijuana, or other recreational drugs that affect the nervous system
  • Major musculoskeletal or neuromuscular disease or disorder of the hands, wrists and limbs
  • Severe Dyskinesia
  • Genetic mutations
  • Major systemic illness or infection

Key Trial Info

Start Date :

June 13 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 13 2025

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT06090292

Start Date

June 13 2023

End Date

June 13 2025

Last Update

October 19 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Toronto Western Hospital

Toronto, Ontario, Canada, M5T 2S8